前收市價 | 217.63 |
開市 | 217.62 |
買盤 | 103.35 x 900 |
賣出價 | 216.87 x 800 |
今日波幅 | 215.68 - 217.79 |
52 週波幅 | 179.59 - 222.76 |
成交量 | |
平均成交量 | 815,720 |
市值 | 18.389B |
Beta 值 (5 年,每月) | 1.05 |
市盈率 (最近 12 個月) | 22.33 |
每股盈利 (最近 12 個月) | 9.70 |
業績公佈日 | 2024年2月14日 - 2024年2月19日 |
遠期股息及收益率 | 2.88 (1.33%) |
除息日 | 2023年11月07日 |
1 年預測目標價 | 241.54 |
Laboratory Corporation of America Holdings (NYSE:LH) Q3 2023 Earnings Call Transcript October 26, 2023 Laboratory Corporation of America Holdings beats earnings expectations. Reported EPS is $3.38, expectations were $3.37. Operator: Welcome to the Laboratory Corporation of America Holdings Third Quarter 2023 Earnings Conference Call. At this time all participants are in listen only mode. After […]
An Alzheimer's drug in injectable form could be the key for Biogen, Eisai to ease pressures and concerns of a limited market and revenue.
While the glitz and glamour of the hottest technology firms organically command our attention, investors should earmark some time for researching value stocks to buy. Fundamentally, these under-the-radar ideas offer the potential for significant returns. After all, it’s generally easier to actualize robust profits starting from a low point to a higher level, as opposed to wagering on strength begetting even more strength. Another element benefiting undervalued value stocks is the “cushion” they